Kangyuan Pharmaceutical is a scarce innovator in traditional Chinese medicine companies
[ad_1]
In the government work report that just passed, the content of the meeting emphasized: “Vigorously promote the construction of a modern industrial system and accelerate the development of new productive forces.” “New productivity” has become a word that has attracted much attention in the whole society this spring. In the pharmaceutical industry, Kangyuan Pharmaceutical has been continuously cultivating new productivity in the traditional Chinese medicine industry by virtue of its research and development and innovation of traditional Chinese medicine.
Traditional Chinese medicine is the material basis for the inheritance, innovation and development of traditional Chinese medicine. It is related to people’s health and life safety. The traditional Chinese medicine industry affects people’s livelihood and well-being and drives economic development. How can the traditional Chinese medicine industry burst out with new productivity vitality in modern society and gather the power of scientific and technological innovation? See how Kangyuan Pharmaceutical does it?
Kangyuan Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine industrial enterprise dedicated to the research, development, production and sales of modern traditional Chinese medicines. The company adheres to the historical mission of “revitalizing Chinese medicine and serving the motherland” and adheres to innovation-driven development. In the course of forty years of development, it has formed an innovative development model with two wings of “traditional Chinese medicine, chemical medicine, and biological medicine” to simultaneously promote the “big health industry” Quality improvement” and “scale expansion” to comprehensively enhance the core competitiveness of enterprises.
Since the “Modern Digital Extraction and Refining Factory of Traditional Chinese Medicine” was included in the first batch of smart manufacturing pilot demonstration projects by the Ministry of Industry and Information Technology – “Pilot Demonstration of Traditional Chinese Medicine Smart Factory” in 2015, Kangyuan Pharmaceutical has continued to increase its investment in the transformation and upgrading of smart manufacturing of traditional Chinese medicine, and gradually Six intelligent workshops or warehouses have been built and improved, including the intelligent extraction and refining workshop of traditional Chinese medicine, the intelligent manufacturing workshop of traditional Chinese medicine injection, the intelligent solid preparation factory of traditional Chinese medicine, the intelligent oral liquid workshop of traditional Chinese medicine, the pre-processing and extraction workshop of traditional Chinese medicine, and the intelligent warehouse. The total construction investment exceeds 1 billion yuan, covering an area of nearly 40,000 square meters and a construction area of over 100,000 square meters. The design adopts intelligent management systems such as online quality control, automated control, and intelligent logistics. The designed preparation production capacity reaches 5 billion hard capsules, 500 million soft capsules, 2.8 billion Chinese medicine tablets, 700 tons of granules, and oral liquids. 380 million vials, 76 million injections, etc., which can achieve an annual output value of 10.3 billion yuan.
With the successive approval of new Chinese medicine drugs for marketing, Kangyuan Pharmaceutical has become the company with the largest number of new drugs on the market among Chinese patent medicine companies, and has been ranked at the forefront of the “China’s Traditional Chinese Medicine R&D Strength Ranking” published by Yaozhi.com for many years in a row.
At the plenary meeting of the Tianjin delegation, National People’s Representative Zhang Boli mentioned that “the experience of modernization of traditional Chinese medicine tells us that the development of traditional Chinese medicine must be combined with modern science and technology.” Kangyuan Pharmaceutical, as a leading company in new traditional Chinese medicines, has always been responsible for revitalizing national medicine. Responsibility, innovation activates new quality productivity of traditional Chinese medicine, insists on innovative development in inheritance, and uses its own practical actions to innovate R&D, quality control and smart manufacturing of traditional Chinese medicine to promote the high-quality development of modern traditional Chinese medicine enterprises.
[ad_2]
Source link
